ESR1 and triple-negative breast carcinoma: The patient with this mutation was 53 years old and diagnosed with triple-negative breast cancer because estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) were negative in immunohistochemistry (IHC) and fluorescence in situ hybridization.